Tirzepatide

Description

Tirzepatide is a synthetic dual incretin receptor agonist targeting both GIP and GLP-1 receptors. Studied in preclinical and clinical metabolic research for glucose regulation and energy balance pathways.

For laboratory and research use only. Not approved for human or animal use.